Pathway-Centric Integrative Analysis Identifies RRM2 as a Prognostic Marker in Breast Cancer Associated with Poor Survival and Tamoxifen Resistance()()()

Breast cancer (BCa) molecular subtypes include luminal A, luminal B, normal-like, HER-2–enriched, and basal-like tumors, among which luminal B and basal-like cancers are highly aggressive. Biochemical pathways associated with patient survival or treatment response in these more aggressive subtypes a...

Descripción completa

Detalles Bibliográficos
Autores principales: Putluri, Nagireddy, Maity, Suman, Kommangani, Ramakrishna, Creighton, Chad J., Putluri, Vasanta, Chen, Fengju, Nanda, Sarmishta, Bhowmik, Salil Kumar, Terunuma, Atsushi, Dorsey, Tiffany, Nardone, Agostina, Fu, Xiaoyong, Shaw, Chad, Sarkar, Tapasree Roy, Schiff, Rachel, Lydon, John P., O’Malley, Bert W., Ambs, Stefan, Das, Gokul M., Michailidis, George, Sreekumar, Arun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198742/
https://www.ncbi.nlm.nih.gov/pubmed/25016594
http://dx.doi.org/10.1016/j.neo.2014.05.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198742/
https://www.ncbi.nlm.nih.gov/pubmed/25016594
http://dx.doi.org/10.1016/j.neo.2014.05.007

Ejemplares similares